Cas no 61-54-1 (Tryptamine)
Tryptamine Chemical and Physical Properties
Names and Identifiers
-
- 2-(1H-Indol-3-yl)ethanamine
- 3-(2-Aminoethyl)indole~2-(3-Indolyl)ethylamine
- 2-(indol-3-yl)ethylamine
- 3-(2-Aminoethyl)Indole
- Tryptamine
- 2-(1H-Indol-3-yl)-ethylamine
- TRYPTAMINE(P)
- (1H-indol-3-yl)ethanamine
- [2-(1H-indol-3-yl)-ethyl]amine
- 1H-Indole-3-ethanaMine
- Indole-ethylamine
- L-TRYPTAMINE
- TRIPTAMINE
- Tryptamin
- 2-(3-Indolyl)ethylamine
- Indol-3-ethylamine
- Indole, 3-(2-aminoethyl)-
- 2-(1H-Indol-3-Yl)Ethan-1-Amine
- 3-Indoleethylamine
- 2-(1H-indol-3-yl)ethylamine
- 2-Indol-3-ylethylamine
- (Amino-2 ethyl)-3 indole
- (Amino-2 ethyl)-3 indole [French]
- Tryptamine, 98%
- 422ZU9N5TV
- APJYDQ
- NCGC00095081-02
- Q409439
- NCGC00014994-01
- 2-(indol-3-yl)ethylamin
- HMS3885E17
- Spectrum2_000873
- 3-(2-amino)ethyl indole
- NCGC00014994-07
- SDCCGMLS-0066798.P001
- 5-22-10-00045 (Beilstein Handbook Reference)
- Tryptamine, analytical standard
- (3-Indolyl)ethylamine
- 2-(1h-indol-3-yl) ethylamine
- Tryptamine, Vetec(TM) reagent grade, 98%
- IDI1_000862
- 3-(2-Aminoethyl)-1H-indole
- FS-3317
- AM807158
- Oprea1_870097
- CCG-40088
- GTPL125
- EINECS 200-510-5
- 5E7B376B-5933-446C-9D88-661B5F480122
- SCHEMBL13006684
- T0890
- Spectrum4_000850
- Lopac0_000061
- KBio2_005529
- 3-indolylethylamine
- FT-0613523
- EC 200-510-5
- BDBM50024210
- KBio1_000862
- 2-indol-3-yl-ethylamine
- T-8095
- SY001383
- CHEBI:16765
- NCGC00095081-01
- TSH
- 3-(beta-aminoethyl)-indole
- HMS502L04
- NCGC00014994-02
- A8532
- bmse000207
- L000946
- HMS1922K18
- 3-Indoleethanamine
- SMR000112268
- KBio3_002903
- LS-82268
- EN300-20412
- (Amino-2 ethyl)-3 indole;3-Indoleethylamine
- KBio2_002961
- AKOS000119468
- NCGC00095081-05
- KBio2_000393
- SCHEMBL26725
- 2-Indol-3-yl-aethylamin
- AE-848/30735051
- beta-(3-Indolyl)ethylamine
- NSC-165212
- DivK1c_000862
- 2-(1H-Indol-3-yl)ethanamine #
- BBL015353
- TRYPTAMINE [MI]
- D08CJK
- 2-(1H-indol-3-yl)-ethyl-amine
- DTXSID2075340
- BSPBio_003400
- NINDS_000862
- NCGC00014994-03
- NCGC00014994-05
- SR-01000075589-5
- 3-[2-Aminoethyl]indole
- SR-01000075589
- SDCCGSBI-0050049.P003
- BRN 0125513
- BRD-K44218819-001-05-1
- SPBio_000945
- KBioGR_001459
- Spectrum_000033
- CCRIS 8959
- Z104478080
- NCGC00095081-03
- UNII-422ZU9N5TV
- NCGC00014994-06
- C00398
- BCP21605
- InChI=1/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H
- CS-D1750
- KBioSS_000393
- STK262895
- DB08653
- NCGC00014994-11
- BP-12561
- .beta.-(3-Indolyl)ethylamine
- Tryptamine, free base
- Spectrum3_001890
- MLS000515794
- NCGC00014994-04
- HY-B2132
- 61-54-1
- s3627
- F2169-0960
- MFCD00005661
- NCGC00095081-04
- Lopac-246557
- Spectrum5_001296
- T-8100
- CHEMBL6640
- SPECTRUM1503922
- HMS2267B18
- NS00006933
- 343-94-2
- tryptaminium(1+)
- tryptaminium cation
- MLSMR
- ALBB-017957
- DB-005731
- Tryptamine Powder
- NCGC00014994-10
-
- MDL： MFCD00005661
- Inchi： 1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2
- InChI Key： APJYDQYYACXCRM-UHFFFAOYSA-N
- SMILES： N1C=C(CCN)C2C=CC=CC1=2
- BRN： 0125513
Computed Properties
- Exact Mass: 160.10000
- Monoisotopic Mass: 127.009184
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 12
- Rotatable Bond Count: 2
- Complexity: 147
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 1.6
- Topological Polar Surface Area: 41.8
Experimental Properties
- Color/Form: Pale-yellow to Yellow-brown Solid
- Density: 0.9787 (rough estimate)
- Melting Point: 113-116?°C (lit.)
- Boiling Point: 137?°C/0.15?mmHg(lit.)
- Flash Point: Fahrenheit: 365 ° f < br / > Celsius: 185 ° C < br / >
- Refractive Index: 1.6210 (estimate)
- PH: 11.07 (10g/l, H2O, 24.7℃)
- Solubility: water: soluble1g/L at 20°C
- Water Partition Coefficient: Negligible
- PSA: 41.81000
- LogP: 2.36940
- Merck: 9796
- Sensitiveness: Air Sensitive
- pka: 10.2(at 25℃)
- Solubility: Soluble in ethanol and acetone, almost insoluble in ether, benzene, chloroform and water.
Tryptamine Security Information
-
Symbol:
- Prompt：warning
- Signal Word：Warning
- Hazard Statement： H315,H319,H335
- Warning Statement： P261,P305+P351+P338
- Hazardous Material transportation number：NONH for all modes of transport
- WGK Germany：3
- Hazard Category Code： 36/37/38
- Safety Instruction： S24/25
- FLUKA BRAND F CODES：8-23
- RTECS：NL4020000
-
Hazardous Material Identification：
- HazardClass：IRRITANT
- Storage Condition：4°C, protect from light
- Risk Phrases：R20/21/22; R36/37/38; R41; R37/38; R22
- Safety Term：S24/25
Tryptamine Customs Data
- HS CODE：29339990
- Customs Data：
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Tryptamine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | 193747-10G |
Tryptamine |
61-54-1 | 10g |
￥407.87 | 2023-12-09 | ||
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | 193747-50G |
Tryptamine |
61-54-1 | 50g |
￥1299.88 | 2023-12-09 | ||
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | V900719-5G |
Tryptamine |
61-54-1 | 98% | 5g |
￥244.9 | 2023-09-06 | |
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | V900719-25G |
Tryptamine |
61-54-1 | 98% | 25g |
￥444.43 | 2023-09-06 | |
| Matrix Scientific | 054474-25g |
2-(1H-Indol-3-yl)-ethylamine, 95% |
61-54-1 | 95% | 25g |
$35.00 | 2023-09-09 | |
| Matrix Scientific | 054474-100g |
2-(1H-Indol-3-yl)-ethylamine, 95% |
61-54-1 | 95% | 100g |
$98.00 | 2023-09-09 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | T0890-25G |
Tryptamine |
61-54-1 | >98.0%(T)(HPLC) | 25g |
￥130.00 | 2024-04-16 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T0647-50 mg |
Tryptamine |
61-54-1 | 99.16% | 50mg |
￥410.00 | 2022-04-26 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T0647-100 mg |
Tryptamine |
61-54-1 | 99.16% | 100MG |
￥574.00 | 2022-04-26 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | T0647-200 mg |
Tryptamine |
61-54-1 | 99.16% | 200mg |
￥738.00 | 2022-04-26 |
Tryptamine Suppliers
Audited Supplier
Audited Supplier
Audited Supplier
Tryptamine Related Literature
-
Song Yang,Xiancui Zhu,Shuangliu Zhou,Shaowu Wang,Zhijun Feng,Yun Wei,Hui Miao,Liping Guo,Fenhua Wang,Guangchao Zhang,Xiaoxia Gu,Xiaolong Mu Dalton Trans. 2014 43 2521
-
Thi Bao Chau Vu,Ivo Kalkman,W. Leo Meerts,Christian Brand,Yuriy N. Svartsov,Sascha Wiedemann,Rainer Weinkauf,Michael Schmitt Phys. Chem. Chem. Phys. 2009 11 2433
-
Kommera Rajkumar,Pathi Suman,Bhimapaka China Raju RSC Adv. 2015 5 73850
-
Marzieh Kamankesh,Abdorreza Mohammadi,Afsaneh Mollahosseini,Shahram Seidi Anal. Methods 2019 11 1898
-
Marzieh Kamankesh,Abdorreza Mohammadi,Afsaneh Mollahosseini,Shahram Seidi Anal. Methods 2019 11 1898
Additional information on Tryptamine
Professional Introduction to Tryptamine (CAS No. 61-54-1)
Tryptamine, a naturally occurring organic compound with the chemical formula C10H13N, is widely recognized for its significant role in the field of biochemistry and pharmacology. The compound is characterized by its indole structure, which is a core component in various biological processes and pharmaceutical applications. With a CAS number of 61-54-1, tryptamine has garnered considerable attention due to its involvement in the synthesis of neurotransmitters and its potential therapeutic benefits.
The importance of tryptamine lies in its structural similarity to serotonin, a key neurotransmitter that regulates mood, appetite, and sleep. This resemblance has made tryptamine a subject of extensive research in the development of drugs targeting neurological and psychiatric disorders. Recent studies have highlighted its role in the modulation of serotonin receptors, which could lead to novel treatments for conditions such as depression, anxiety, and obsessive-compulsive disorder (OCD).
In the realm of pharmaceutical research, tryptamine derivatives have been explored for their potential to interact with various biological pathways. For instance, modifications to the indole ring have led to the development of compounds with enhanced binding affinity to serotonin receptors. These derivatives are being tested in clinical trials for their efficacy in treating mood disorders and have shown promising results in preclinical studies.
The biosynthesis of tryptamine is another area where significant advancements have been made. Researchers have identified key enzymes and metabolic pathways involved in the conversion of tryptophan, an essential amino acid, into tryptamine. This understanding has not only shed light on the fundamental processes governing neurotransmitter production but also opened avenues for genetic engineering approaches aimed at enhancing tryptamine levels in patients with deficiencies.
Moreover, tryptamine has found applications beyond traditional pharmacology. It serves as a precursor in the synthesis of various natural products and has been utilized in biochemical assays to study enzyme kinetics and receptor binding mechanisms. The compound's versatility makes it a valuable tool in both academic research and industrial applications.
Recent innovations in synthetic chemistry have enabled the production of tryptamine derivatives with tailored properties for specific therapeutic purposes. Techniques such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions have improved the efficiency and scalability of tryptamine synthesis. These advancements are crucial for meeting the growing demand for high-purity tryptamine used in pharmaceutical manufacturing.
The environmental impact of tryptamine production has also been a focus of recent research. Sustainable synthetic routes that minimize waste and reduce energy consumption are being developed to ensure the long-term viability of tryptamine-based therapies. Such efforts align with global initiatives aimed at promoting green chemistry practices across all industries.
In conclusion, tryptamine (CAS No. 61-54-1) remains a cornerstone compound in biochemistry and pharmacology due to its multifaceted roles in biological systems and therapeutic applications. Ongoing research continues to uncover new possibilities for leveraging its unique properties, from developing novel drugs to advancing our understanding of fundamental biological processes. As scientific knowledge evolves, so too will the applications and significance of this remarkable compound.
61-54-1 (Tryptamine) Related Products
- 1010-95-3(5-Methyltryptamine Hydrochloride)
- 62500-88-3(5-ethyl-1H-Indole-3-ethanamine)
- 1821-47-2(2-(5-Methyl-1H-indol-3-yl)ethanamine)
- 362049-48-7(Tryptamine-β,β-d2 HCl)
- 362049-49-8(Tryptamine-α,α-d2 HCl)
- 14490-05-2(2-(7-Methyl-1H-indol-3-yl)ethanamine)
- 343-94-2(Tryptamine hydrochloride)
- 340257-60-5(Tryptamine-d)
- 55795-89-6(1H-Indole-2-ethanamine,5-methyl-, hydrochloride (1:1))
- 159730-12-8(6-Methyltryptamine Hydrochloride)
